Inventor · Malvern, PA, US

George Heavner

57Patents
18h-index
37Co-inventors
84Inventor score

Filing activity: Jul 1, 1976 → Feb 14, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US7250165B2 Anti-TNF antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 187 Expired
US4289759A Immunoregulatory diketopiperazine compounds Human Necessities 150 Expired
US7521206B2 Anti-TNF antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 81 Expired
US5618785A Peptide inhibitors of selectin binding Human Necessities 64 Expired
US5710123A Peptide inhibitors of selectin binding Human Necessities 63 Expired
US4331595A Immunoregulatory diketopiperazine compounds Human Necessities 45 Expired
US6111065A Peptide inhibitors of inflammation mediated by selectins Human Necessities 42 Expired
US5753617A Peptide inhibitors of cellular adhesion Human Necessities 42 Expired
US6528487B1 Peptide inhibitors of inflammation mediated by selectins Human Necessities 41 Expired
US7393662B2 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 40 Expired
US4505853A Enzyme-resistant immunomodulatory peptides Emerging Cross-Sectional Technologies 40 Expired
US7718176B2 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 35 Active
US4547489A Conformationally restricted thymopentin-like compounds Emerging Cross-Sectional Technologies 33 Expired
US4261886A Peptides having thymopoietin-like activity Emerging Cross-Sectional Technologies 32 Expired
US5298490A Tetra and penta-peptides useful in regulating the immune system Human Necessities 26 Expired
US7691378B2 Anti-TNF antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 23 Active
US7074755B2 Erythropoietin conjugate compounds with extended half-lives Human Necessities 21 Expired
US4629723A Potent thymopentin analogs Emerging Cross-Sectional Technologies 19 Expired
US7163920B2 Peptide with osteogenic activity Human Necessities 17 Expired
US7241733B2 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses Chemistry; Metallurgy 16 Expired
US4028401A (Substituted)ureidoacetohydroxamic acids Emerging Cross-Sectional Technologies 13 Expired
US4215111A Peptides having ubiquitin-like activity Human Necessities 13 Expired
US4866121A B cell differentiating peptides and conjugates thereof Chemistry; Metallurgy 12 Expired
US9321836B2 Anti-TNF antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 12 Active
US4397842A Peptides having thymopoietin-like activity Emerging Cross-Sectional Technologies 11 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.